Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models

BACKGROUND: Ovarian cancer remains an on-going challenge mainly due to the development of drug resistance and also because the cancer is likely to have metastasized at the time of diagnosis. Currently, chemotherapy based on platinum drugs such as cisplatin is the primary treatment for the disease. C...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Al-Eisawi, Zaynab, Beale, Philip, Chan, Charles, Yu, Jun Q, Huq, Fazlul
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2013
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3826510/
https://ncbi.nlm.nih.gov/pubmed/24209693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-6-78
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares